WCN26-8089 EFFICACY AND SAFETY OF TELITACICEPT IN PRIMARY IMMUNOGLOBULIN A NEPHROPATHY PATIENTS WITH SEVERELY IMPAIRED RENAL FUNCTION

Read full text Summarise with VIRAT
Authors: Yanrong Yang, Ziyan Shen, Han Zhang, Shaomin Gong, Shuangxin Yuan, Xiaoqiang Ding, Xiaoyan Zhang, Yulin Wang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106308–106308
Publication date
25 March 2026
Language
EN